One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
作者： Maria Sole Chimenti , Giulia Lavinia Fonti , Paola Conigliaro , Flavia Sunzini , Rossana Scrivo
DOI: 10.1080/14712598.2020.1761957
关键词: Internal medicine 、 Psoriatic arthritis 、 Ankylosing spondylitis 、 Retention rate 、 Randomized controlled trial 、 Secukinumab 、 Observational study 、 Multicenter study 、 Medicine
摘要: Secukinumab (SEC) is effective for ankylosing spondylitis (AS) and psoriatic arthritis (PsA) in randomized trials, but real-life data are lacking. Real-life, prospective observational study on 169 ...
sci-hub.se 参考文章(45)
Nigil Haroon, Robert D. Inman, Thomas J. Learch, Michael H. Weisman, MinJae Lee, Mohammad H. Rahbar, Michael M. Ward, John D. Reveille, Lianne S. Gensler, The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis & Rheumatism. ,vol. 65, pp. 2645- 2654 ,(2013) , 10.1002/ART.38070
PJ Mease, IB McInnes, B Kirkham, A Kavanaugh, P Rahman, D van der Heijde, R Landewé, P Nash, L Pricop, J Yuan, HB Richards, S Mpofu, FUTURE 1 Study Group., None, Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. The New England Journal of Medicine. ,vol. 373, pp. 1329- 1339 ,(2015) , 10.1056/NEJMOA1412679
Sjef Van Der Linden, Hans A. Valkenburg, Arnold Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis Arthritis & Rheumatism. ,vol. 27, pp. 361- 368 ,(1984) , 10.1002/ART.1780270401
Rosario Peluso, Salvatore Iervolino, Maria Vitiello, Vincenzo Bruner, Gelsy Lupoli, Matteo Nicola Dario Di Minno, Extra-articular manifestations in psoriatic arthritis patients Clinical Rheumatology. ,vol. 34, pp. 745- 753 ,(2015) , 10.1007/S10067-014-2652-9
G Walter Canonica, Expert review of clinical immunology : a breakthrough in the future. Expert Review of Clinical Immunology. ,vol. 1, pp. 1- 2 ,(2005) , 10.1586/1744666X.1.1.1
Jean-Pierre Després, Isabelle Lemieux, Abdominal obesity and metabolic syndrome Nature. ,vol. 444, pp. 881- 887 ,(2006) , 10.1038/NATURE05488
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
Jonathan P Sherlock, Barbara Joyce-Shaikh, Scott P Turner, Cheng-Chi Chao, Manjiri Sathe, Jeff Grein, Daniel M Gorman, Edward P Bowman, Terrill K McClanahan, Jennifer H Yearley, Gérard Eberl, Christopher D Buckley, Robert A Kastelein, Robert H Pierce, Drake M LaFace, Daniel J Cua, IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells Nature Medicine. ,vol. 18, pp. 1069- 1076 ,(2012) , 10.1038/NM.2817
D van der Heijde, E Lie, T K Kvien, J Sieper, F Van den Bosch, J Listing, J Braun, R Landewe, , ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Annals of the Rheumatic Diseases. ,vol. 68, pp. 1811- 1818 ,(2009) , 10.1136/ARD.2008.100826
Dominique Baeten, Maxime Breban, Rik Lories, Georg Schett, Joachim Sieper, None, Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype Arthritis & Rheumatism. ,vol. 65, pp. 12- 20 ,(2013) , 10.1002/ART.37829